Gangliogliomas are rare, low-grade tumors that affect both glial cells (responsible for providing the structural support of the central nervous system) and neuronal cells (the functioning component of the central nervous system). These tumors occur most commonly in the cerebrum, the part of the brain that controls motor, sensory and higher mental function. They rarely spread to other parts of the brain or transform into higher-grade tumors. Children with certain genetic syndromes, including neurofibromatosis 1 and tuberous sclerosis, are at high risk of developing glial tumors, including gangliogliomas; however, most of these tumors develop spontaneously.
Children with gangliogliomas are treated at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center through our Glioma Program. Continue reading to learn more about gangliogliomas or visit the Glioma Program homepage to learn about our expertise and treatment options for this condition.
Since gangliogliomas grow relatively slowly, a child may have been having symptoms for many months prior to diagnosis, or symptoms may appear more suddenly. Many children with gangliogliomas first present with seizures. Other symptoms are associated with increased pressure in the brain, including:
A physician may order a number of different tests to best diagnose the tumor. In addition to a physical exam, medical history and neurological exam (which tests reflexes, muscle strength, eye and mouth movement, coordination and alertness), those tests may include:
After all tests are completed, doctors will be able to outline the best treatment options.
A child’s physician will determine a specific course of treatment based on several factors. Some therapies will treat the tumor while others are intended to address complications of the disease or side effects of the treatment. These treatments include:
Through ongoing education, care and support, we are preparing cancer survivors for the road ahead. Learn about our extensive services for survivors of pediatric cancer.